HUTCHISON CHINA/S (NASDAQ:HCM) saw unusually-high trading volume on Friday . Approximately 6,029,143 shares traded hands during trading, an increase of 3,362% from the previous session’s volume of 174,164 shares.The stock last traded at $34.47 and had previously closed at $34.31.
HCM has been the topic of a number of analyst reports. BidaskClub raised shares of HUTCHISON CHINA/S from a “hold” rating to a “buy” rating in a research note on Tuesday, October 2nd. Zacks Investment Research upgraded shares of HUTCHISON CHINA/S from a “sell” rating to a “hold” rating in a research report on Tuesday.
The stock has a market cap of $4.80 billion, a price-to-earnings ratio of -156.68 and a beta of 0.01. The company has a debt-to-equity ratio of 0.06, a quick ratio of 4.55 and a current ratio of 4.67.
Several institutional investors and hedge funds have recently made changes to their positions in HCM. OppenheimerFunds Inc. increased its position in shares of HUTCHISON CHINA/S by 76.5% during the second quarter. OppenheimerFunds Inc. now owns 2,972,947 shares of the company’s stock valued at $89,604,000 after acquiring an additional 1,288,177 shares during the last quarter. Alps Advisors Inc. acquired a new stake in shares of HUTCHISON CHINA/S during the second quarter valued at about $5,785,000. Allianz Asset Management GmbH increased its position in shares of HUTCHISON CHINA/S by 47.3% during the third quarter. Allianz Asset Management GmbH now owns 447,494 shares of the company’s stock valued at $14,405,000 after acquiring an additional 143,765 shares during the last quarter. State of New Jersey Common Pension Fund D acquired a new stake in shares of HUTCHISON CHINA/S during the second quarter valued at about $2,651,000. Finally, Bellevue Group AG increased its position in shares of HUTCHISON CHINA/S by 20.3% during the third quarter. Bellevue Group AG now owns 400,029 shares of the company’s stock valued at $12,877,000 after acquiring an additional 67,493 shares during the last quarter. Institutional investors and hedge funds own 11.45% of the company’s stock.
WARNING: “HUTCHISON CHINA/S (HCM) Sees Large Volume Increase” was published by Community Financial News and is owned by of Community Financial News. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. and international trademark and copyright law. The correct version of this news story can be accessed at https://www.com-unik.info/2018/11/30/hutchison-china-s-hcm-sees-large-volume-increase.html.
HUTCHISON CHINA/S Company Profile (NASDAQ:HCM)
Hutchison China MediTech Limited, a biopharmaceutical company, engages in the research, development, manufacture, and sale of pharmaceuticals and healthcare products primarily in the People's Republic of China and Hong Kong. It operates through Innovation Platform and Commercial Platform segments.
Featured Story: The Discount Rate – What You Need to Know
Receive News & Ratings for HUTCHISON CHINA/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HUTCHISON CHINA/S and related companies with MarketBeat.com's FREE daily email newsletter.